Completed Induction Phase Analysis of MAGNIFY: Phase 3b Study of Lenalidomide plus Rituximab (R2) Followed by Maintenance in Relapsed/Refractory Indolent Non-Hodgkin
AMERICAN JOURNAL OF HEMATOLOGY（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要